Let's Get Real.
Seattle Genetics is a biotech company that researches ways to improve people’s lives. The goals of the company are to be innovative, help patients, scientific excellence, teamwork and to create a strong work environment for their employees. One of the focuses of the Seattle Genetics biotechnology company is the clinical studies of cancer treatments. The company is focusing on how to use antibody-drug conjugates to treat cancerous cells within the body.
Dr. Clay Siegall is one of the co-founders, president and CEO of the Seattle Genetics biotechnology company. He was one of the co-founders back in 1998. The company has made a considerable amount of money with Dr. Siegall leading the company. Approximately the company has made some three hundred million dollars from the ADCs treatments under the lead of Dr. Siegall. The company has made six hundred, seventy-five million dollars in financing for their research. This is thanks to Dr. Clay Siegall.
Ultragenyx Pharmaceutical, Mirna Therapeutics and Alder Biopharmaceuticals are pharmaceutical companies that Dr. Clay Siegall is a part of the Board of Directors of. Dr. Clay Siegall studied zoology and genetics. He graduated with a Bachelor’s of Zoology and completed his education with a PhD in Genetics from the George Washington University located in Washington, D.C. He resides in Bothell, Washington. Dr. Clay Siegall was specially honored for his math, science and entrepreneur skills when he was studying at the University of Maryland.
With the help of Dr. Clay Siegall pioneering the push of ADCs to treat cancer, it appears to be very hopeful that the company will find a cure for cancer.